RE: SNG001 a broad spectrum antiviral25 Oct 2020 22:54
Chia,
As always , we should take the prospects of SNG001 with optimism but we still need P3 confirmation for Covid , we need to finish the P2b trial in COPD before doing a P3 in COPD
As for asthma and any other indication well the journey will be much longer
Eyes to the stars but feet on the ground ......
Btw , we got the P3 trial and the placing ....as predicted